Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

GRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Galera Therapeutics Insider Trading History Chart

Galera Therapeutics Share Price & Price History

^$0.19

▼ -0.02 (-9.70%)

As of 04/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

From Colonial Metals | Ad

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

Galera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/16/2023	Mark Bachleda	Insider	Buy	11,000	$2.25	$24,750.00	11,000
3/13/2023	Chris Degnan	CFO	Buy	10,000	$1.96	$19,600.00	10,000
3/10/2023	Mel Sorensen	CEO	Buy	100,000	$1.68	$168,000.00	332,044
12/17/2021	Linda West	Director	Buy	20,000	$2.74	$54,800.00
6/15/2021	Linda West	Director	Buy	10,000	$9.13	$91,300.00	40,000
6/2/2021	Linda West	Director	Buy	10,000	$8.65	$86,500.00	30,000

The Next Step of Their Control Is Here …

From Weiss Ratings | Ad

Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.

4 simple steps to protect your privacy and money before it’s too late.

SEC Filings (Institutional Ownership Changes) for Galera Therapeutics (NASDAQ:GRTX)

50.77% of Galera Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/31/2024	abrdn plc	898,374	$0.13M	0.0%	N/A	1.652%
8/11/2023	Sectoral Asset Management Inc.	2,005,054	$6.26M	1.0%	-4.5%	4.673%
8/4/2023	Parallel Advisors LLC	7,867	$25K	0.0%	N/A	0.018%
8/2/2023	Baystate Wealth Management LLC	47,695	$0.15M	0.0%	N/A	0.111%
7/27/2023	Pinnacle Associates Ltd.	47,695	$0.15M	0.0%	N/A	0.111%
7/24/2023	Vontobel Holding Ltd.	20,000	$62K	0.0%	N/A	0.047%
7/21/2023	Global Assets Advisory LLC	24,500	$73K	0.1%	N/A	0.057%
7/11/2023	Good Life Advisors LLC	11,250	$35K	0.0%	N/A	0.026%
5/12/2023	Sectoral Asset Management Inc.	2,098,565	$5.37M	1.0%	+25.9%	4.891%
5/12/2023	Mirabella Financial Services LLP	57,000	$6.66M	1.0%	N/A	0.133%
5/1/2023	Virtu Financial LLC	20,195	$52K	0.0%	N/A	0.047%
4/14/2023	Raymond James Financial Services Advisors Inc.	23,475	$60K	0.0%	N/A	0.055%
2/10/2023	Sectoral Asset Management Inc.	1,666,666	$2.48M	0.5%	N/A	5.848%
8/12/2022	Ensign Peak Advisors Inc	151,777	$0.20M	0.0%	+281.6%	0.566%
2/11/2022	Ensign Peak Advisors Inc	39,775	$0.15M	0.0%	N/A	0.150%
2/10/2022	Acadian Asset Management LLC	96,027	$0.44M	0.0%	N/A	0.363%
2/8/2022	Raymond James Financial Services Advisors Inc.	22,311	$0.10M	0.0%	-26.3%	0.084%
1/28/2022	Taylor Wealth Management Partners	11,635	$53K	0.0%	-79.9%	0.044%
1/25/2022	Belvedere Trading LLC	96,486	$0.26M	0.0%	N/A	0.365%
11/17/2021	Altium Capital Management LP	300,605	$2.44M	0.5%	+36.7%	1.137%
11/15/2021	Marshall Wace LLP	83,050	$0.67M	0.0%	-28.7%	0.315%
11/12/2021	AIGH Capital Management LLC	2,036,495	$16.50M	3.5%	+0.7%	7.724%
10/26/2021	Taylor Wealth Management Partners	58,012	$0.47M	0.2%	-11.0%	0.220%
9/22/2021	Nan Fung Group Holdings Ltd	613,223	$6.03M	1.9%	N/A	2.326%
8/25/2021	Marshall Wace LLP	116,508	$1.15M	0.0%	+115.3%	0.442%
8/17/2021	Worth Venture Partners LLC	469,174	$4.61M	1.7%	+119.0%	1.779%
8/17/2021	Millennium Management LLC	118,548	$1.17M	0.0%	N/A	0.450%
8/17/2021	Bridgeway Capital Management LLC	110,000	$1.08M	0.0%	+22.2%	0.417%
8/16/2021	State Street Corp	15,964	$0.16M	0.0%	-87.5%	0.061%
8/16/2021	Tibra Equities Europe Ltd	36,900	$0.36M	0.1%	N/A	0.140%
8/16/2021	Marshall Wace LLP	116,508	$1.15M	0.0%	+115.3%	0.442%
8/13/2021	Renaissance Technologies LLC	24,170	$0.24M	0.0%	-34.8%	0.092%
8/13/2021	Northern Trust Corp	14,795	$0.15M	0.0%	-84.4%	0.056%
8/13/2021	Altium Capital Management LP	219,900	$2.16M	0.5%	N/A	0.834%
8/13/2021	Jump Financial LLC	18,000	$0.18M	0.0%	N/A	0.071%
8/13/2021	Geode Capital Management LLC	71,256	$0.70M	0.0%	-38.7%	0.282%
8/13/2021	Vanguard Group Inc.	481,524	$4.73M	0.0%	-4.9%	1.907%
8/12/2021	AIGH Capital Management LLC	2,022,889	$19.89M	3.6%	+121.7%	8.010%
8/12/2021	Trexquant Investment LP	11,237	$0.11M	0.0%	N/A	0.044%
8/12/2021	JPMorgan Chase & Co.	35,973	$0.35M	0.0%	+52.1%	0.142%
8/12/2021	Ergoteles LLC	40,000	$0.39M	0.0%	N/A	0.158%
8/11/2021	BlackRock Inc.	185,141	$1.82M	0.0%	-68.7%	0.733%
8/11/2021	Deutsche Bank AG	275,935	$2.71M	0.0%	+4,367.1%	1.093%
8/5/2021	US Bancorp DE	10,579	$0.10M	0.0%	N/A	0.042%
6/10/2021	Perceptive Advisors LLC	254,664	$2.25M	0.0%	-21.6%	1.008%
5/19/2021	Worth Venture Partners LLC	214,242	$1.89M	0.9%	N/A	0.848%
5/17/2021	Schonfeld Strategic Advisors LLC	54,488	$0.48M	0.0%	N/A	0.216%
5/17/2021	Perceptive Advisors LLC	254,664	$2.25M	0.0%	-21.6%	1.008%
5/17/2021	Caas Capital Management LP	273,210	$2.41M	0.0%	+53.4%	1.082%
5/17/2021	Sphera Funds Management LTD.	323,348	$2.85M	0.2%	-30.9%	1.280%
5/17/2021	Novo Holdings A S	2,459,021	$21.69M	0.9%	-16.9%	9.737%
5/17/2021	Goldman Sachs Group Inc.	12,805	$0.11M	0.0%	-21.9%	0.051%
5/14/2021	Weiss Multi Strategy Advisers LLC	26,573	$0.23M	0.0%	-13.7%	0.105%
5/13/2021	Renaissance Technologies LLC	37,081	$0.33M	0.0%	+78.5%	0.147%
5/13/2021	Bank of New York Mellon Corp	32,303	$0.29M	0.0%	-5.7%	0.128%
5/12/2021	Northern Trust Corp	94,945	$0.84M	0.0%	-3.9%	0.376%
5/12/2021	Geode Capital Management LLC	116,266	$1.03M	0.0%	+2.2%	0.460%
5/12/2021	Panagora Asset Management Inc.	36,144	$0.32M	0.0%	+7.2%	0.143%
5/12/2021	UBS Group AG	4,349	$38K	0.0%	+122.3%	0.017%
5/7/2021	BlackRock Inc.	591,727	$5.22M	0.0%	+10.2%	2.343%
2/25/2021	Hsbc Holdings PLC	13,274	$0.14M	0.0%	N/A	0.053%
2/19/2021	JPMorgan Chase & Co.	22,564	$0.23M	0.0%	+262.1%	0.090%
2/16/2021	Squarepoint Ops LLC	12,428	$0.13M	0.0%	N/A	0.050%
2/12/2021	Caas Capital Management LP	178,141	$1.82M	0.0%	N/A	0.714%
2/11/2021	Northern Trust Corp	98,763	$1.01M	0.0%	-5.0%	0.396%
2/11/2021	Frazier Management LLC	241,000	$2.47M	0.2%	N/A	0.966%
2/10/2021	Renaissance Technologies LLC	20,770	$0.21M	0.0%	+58.9%	0.083%
2/10/2021	Panagora Asset Management Inc.	33,731	$0.35M	0.0%	+4,795.6%	0.135%
2/9/2021	Wells Fargo & Company MN	34,611	$0.35M	0.0%	+407.9%	0.139%
2/9/2021	Bank of New York Mellon Corp	34,273	$0.35M	0.0%	+42.0%	0.137%
2/8/2021	New York State Common Retirement Fund	8,800	$90K	0.0%	+1,000.0%	0.035%
2/5/2021	BlackRock Inc.	536,965	$5.49M	0.0%	+27.1%	2.152%
2/4/2021	State of Wisconsin Investment Board	12,300	$0.13M	0.0%	N/A	0.049%
2/2/2021	Taylor Wealth Management Partners	64,753	$0.66M	0.3%	+4.2%	0.260%
11/17/2020	VR Adviser LLC	51,653	$0.47M	0.1%	N/A	0.207%
11/13/2020	Morgan Stanley	2,777	$25K	0.0%	-52.1%	0.011%
11/10/2020	State Street Corp	82,772	$0.75M	0.0%	-3.1%	0.333%
11/6/2020	BlackRock Inc.	422,640	$3.82M	0.0%	+6.4%	1.699%
10/14/2020	Taylor Wealth Management Partners	62,171	$0.56M	0.3%	+3.7%	0.250%
8/25/2020	Nuveen Asset Management LLC	14,027	$100K	0.0%	N/A	0.056%
8/20/2020	Charles Schwab Investment Management Inc.	18,833	$0.14M	0.0%	N/A	0.076%
8/17/2020	Jacobs Levy Equity Management Inc.	36,161	$0.26M	0.0%	N/A	0.145%
8/14/2020	Bank of America Corp DE	9,737	$69K	0.0%	+206.0%	0.039%
8/13/2020	Tekla Capital Management LLC	1,041,845	$7.44M	0.3%	+150.0%	4.197%
8/12/2020	American International Group Inc.	5,348	$38K	0.0%	+427.9%	0.022%
8/12/2020	Bank of New York Mellon Corp	24,131	$0.17M	0.0%	+108.1%	0.097%
7/27/2020	Taylor Wealth Management Partners	59,930	$0.43M	0.2%	N/A	0.241%
7/20/2020	TCI Wealth Advisors Inc.	5,962	$43K	0.0%	N/A	0.024%
7/17/2020	Raymond James Financial Services Advisors Inc.	28,561	$0.20M	0.0%	N/A	0.115%
6/19/2020	State Street Corp	15,084	$0.14M	0.0%	N/A	0.061%
5/15/2020	RA Capital Management L.P.	893,115	$8.49M	0.3%	-15.3%	3.598%
5/15/2020	Squarepoint Ops LLC	12,670	$0.12M	0.0%	N/A	0.051%
5/15/2020	Weiss Multi Strategy Advisers LLC	48,492	$0.46M	0.0%	-19.2%	0.195%
5/15/2020	Morgan Stanley	4,747	$45K	0.0%	+101.5%	0.019%
5/14/2020	Wells Fargo & Company MN	5,285	$50K	0.0%	+3,757.7%	0.021%
5/14/2020	Geode Capital Management LLC	49,217	$0.47M	0.0%	+31.7%	0.198%
5/14/2020	Sphera Funds Management LTD.	475,677	$4.52M	0.6%	+0.9%	1.917%
5/11/2020	Ensign Peak Advisors Inc	8,925	$85K	0.0%	-64.3%	0.036%
5/11/2020	State Street Corp	15,084	$0.14M	0.0%	N/A	0.061%
5/6/2020	Bank of New York Mellon Corp	11,596	$0.11M	0.0%	N/A	0.047%

Data available starting January 2016

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also developing GC4711, a dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is based in Malvern, Pennsylvania.

Today's Range

Now: $0.19

$0.19

$0.22

50 Day Range

MA: $0.20

$0.14

$0.27

52 Week Range

Now: $0.19

$0.09

$3.59

Volume

2,160,753 shs

Average Volume

2,345,361 shs

Market Capitalization

$10.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.17

Who are the company insiders with the largest holdings of Galera Therapeutics?: Galera Therapeutics' top insider investors include:
Mel Sorensen (CEO)
Mark Bachleda (Insider)
Chris Degnan (CFO)
Learn More about top insider investors at Galera Therapeutics.